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Chitosan has been used as source of potential bioactive material in the past few 
decades. However, in the biomedical field, chitooligosaccharides (COS) are more 
applicable due to their water solubility and higher absorption profiles at intestinal level 
— quickly getting into the blood flow and having systemic biological effects in the 
organism. To explore the anti-inflammatory activities of COS, we tested two COS 
mixtures (obtained via enzymatic, with molecular weight <3 and <5 kDa) at several 
concentrations, by carrageenan-induced paw edema methodology, in mice. The 
inflammatory response was quantified by increase in paw size (edema) which is 
maximal around five-hour postcarrageenan injection, and is modulated by inhibitors of 
specific molecules within the inflammatory cascade. COS showed anti-inflammatory 
action, which increased with the molecular weight. COS<5 kDa even showed higher 
effect than the control, indomethacin, after two hours, with no harmful secondary 
effects.  
Our data suggest that COS possesses anti-inflammatory effect, dose and MW-
dependent. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
